These 373M CLEAT options were already issued and approved by shareholders. This prospectus doesn’t create new dilution — it just enables existing options to be traded on-market.
The $42k cost is a one-off legal/compliance expense to meet ASIC/ASX rules. Standard practice.
If these options are exercised at $0.032, CLE receives up to $11.9M in funding, which strengthens the balance sheet without needing a placement.
Yes, they add liquidity and some short-term supply, but many holders may exercise rather than flip, especially with CLE trading ~50% above strike.
These 373M CLEAT options were already issued and approved by...
Add to My Watchlist
What is My Watchlist?
